Intravenous autologous bone marrow mononuclear cells for ischemic stroke
- 25 April 2011
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 70 (1), 59-69
- https://doi.org/10.1002/ana.22458
Abstract
Objective: Cellular therapy is an investigational approach for stroke. Mononuclear cells (MNCs) from the bone marrow reduce neurological deficits in animal stroke models. We determined if autologous MNC infusion was feasible and safe in patients with ischemic stroke. Methods: We conducted an open‐label prospective study of a bone marrow harvest followed by readministration of autologous MNCs in 10 patients, 18 to 80 years old, with acute middle cerebral artery ischemic stroke. Bone marrow was aspirated from the iliac crest, and MNCs were separated at a Good Manufacturing Practices facility and administered intravenously up to a maximum of 10 million cells/kg. The harvest and infusion had to occur between 24 and 72 hours after stroke. Patients were monitored for 6 months. Results: Bone marrow aspiration was successfully completed in all patients. Eight received 10 million cells/kg, and 2 received ≥7 million cells/kg. There were no significant adverse events related to harvest or infusion. Two patients had infarct expansion between enrollment and harvest and underwent hemicraniectomy after cell infusion. One patient died at 40 days due to a pulmonary embolism related to the stroke. There were no study‐related severe adverse events. Median National Institutes of Health Stroke Scale score was 13 before harvest, 8 at 7 days, and 3 at 6 months. At 6 months, all surviving patients had shifted down by at least 1 point on the modified Rankin Scale compared to day 7. Seven of 10 patients achieved a Barthel Index ≥90. Interpretation: This study suggests that a bone marrow harvest and reinfusion of autologous MNCs were safe and feasible in acute stroke patients. ANN NEUROL 2011;Keywords
This publication has 23 references indexed in Scilit:
- Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic strokeJournal of Neuroscience Research, 2011
- Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experienceCytotherapy, 2010
- Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic strokeJournal of Neuroscience Research, 2010
- Optimizing the success of cell transplantation therapy for strokeNeurobiology of Disease, 2010
- Autologous Bone Marrow Mononuclear Cells Enhance Recovery after Acute Ischemic Stroke in Young and Middle-Aged RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Marrow stromal cell transplantation in stroke and traumatic brain injuryNeuroscience Letters, 2009
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- S tem Cell T herapies as an E merging P aradigm in S troke (STEPS)Stroke, 2009
- Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemiaProceedings of the National Academy of Sciences of the United States of America, 2007
- Proof-of-Principle Phase II MRI Studies in StrokeStroke, 2006